Two Sigma Securities, LLC Aurinia Pharmaceuticals Inc. Transaction History

Two Sigma Securities, LLC

  • $5.78 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$7.13 - $9.49 $36,248 - $48,247
5,084 Added 47.72%
15,738 $141,000
Q3 2023

Nov 14, 2023
SELL
$7.77 - $12.27 $103,442 - $163,350
-13,313 Reduced 55.55%
10,654 $82,000
Q2 2023

Aug 14, 2023
BUY
$8.96 - $11.69 $214,744 - $280,174
23,967 New
23,967 $232,000
Q4 2022

Feb 14, 2023
BUY
$4.11 - $8.14 $82,306 - $163,011
20,026 New
20,026 $86,000

Others Institutions Holding AUPH

# of Institutions
209
Shares Held
58.7M
Call Options Held
1.14M
Put Options Held
1.51M
View Full List

About Aurinia Pharmaceuticals Inc.

AUPH Quotes by TradingView
  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.15B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email